Sonova Holding (OTCMKTS:SONVY) Short Interest Update

Sonova Holding (OTCMKTS:SONVY) was the recipient of a large decrease in short interest in February. As of February 27th, there was short interest totaling 1,056 shares, a decrease of 90.9% from the February 12th total of 11,643 shares. Based on an average trading volume of 74,022 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the company’s stock are sold short. Approximately 0.0% of the company’s stock are sold short. Based on an average trading volume of 74,022 shares, the short-interest ratio is presently 0.0 days.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on SONVY shares. Royal Bank Of Canada raised Sonova to a “moderate buy” rating in a research note on Tuesday, November 18th. Zacks Research upgraded shares of Sonova from a “strong sell” rating to a “hold” rating in a report on Monday, February 9th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Sonova Stock Performance

Shares of OTCMKTS SONVY traded up $1.56 on Tuesday, reaching $51.10. 103,528 shares of the company’s stock traded hands, compared to its average volume of 30,747. The business’s 50 day simple moving average is $52.85 and its two-hundred day simple moving average is $53.82. Sonova has a 12 month low of $47.55 and a 12 month high of $68.76. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.24 and a quick ratio of 0.91.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.